Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06186765 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

F15 Recharge Free Axonics SNM System Clinical Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 2 of 3 entries
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 3 of 4 entries
    • Site details revised at 1 of 16 sites
  2. 6 versions Re-verified since May 11, 2026, no change to tracked fieldsv18-v23
  3. Primary completion pushed from Mar 2026 to Dec 2026
    • Study completion pushed from Mar 2027 to Dec 2027
    v17
  4. 2 versions Re-verified since Feb 5, 2026, no change to tracked fieldsv15-v16
  5. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 144
    • Site details revised at 16 of 16 sites
    v14
Show 12 earlier versionsHide 12 earlier versions
  1. Re-verified, no change to tracked fieldsv13
  2. Site details revised at 1 of 16 sitesv12
  3. Site contacts updated at 1 of 16 sitesv11
  4. Site details revised at 4 of 16 sitesv10
  5. Primary completion date: Jan 2026 to Mar 2026
    • Study completion date: Jan 2027 to Mar 2027
    • Study sites revised (16)
    v9
  6. Primary endpoints: 4 to 3v8 Show 5 more changesShow less
    • Primary completion date: Aug 2025 to Jan 2026
    • Study completion date: Sep 2026 to Jan 2027
    • Secondary endpoints: details revised at 1 of 4 entries
    • Site details revised at 3 of 16 sites
    • Study description shortened, about 3 words
  7. Enrollment target: 130 to 150
    • Study completion date: Jun 2026 to Sep 2026
    v7
  8. Study sites: 14 to 16v6
  9. Primary endpoints revised (4)
    • Study sites: 13 to 14
    • Primary completion date: Mar 2025 to Aug 2025
    • Secondary endpoints revised (4)
    v5
  10. Study sites: 9 to 13v4
  11. Enrollment target: 110 to 130
    • Study sites: 2 to 9
    • Primary completion date: Dec 2024 to Mar 2025
    • Study completion date: Dec 2025 to Jun 2026
    v3
  12. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Dec 2023 to Dec 8, 2023
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Axonics, Inc.
5 trials monitored
See 1 trial at risk
Multicenter, prospective, non randomized, single arm evaluation of patients with overactive bladder (OAB) and/or fecal incontinence (FI) employing the Axonics recharge free SNM System.
Trial Details
NCT Number NCT06186765
Lead Sponsor Axonics, Inc.
Conditions
(from sponsor)		 Urinary Urge Incontinence (UUI), Urinary Frequency (UF), Fecal Incontinence (FI)
Related terms Fecal Incontinence, Urinary Incontinence, Urge
Enrollment 144 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov